中文简体
中文简体 English
  • HOME
  • ABOUT US
    Company Profile Company Culture Company Honor
  • R&D
    Technology Platform Pipelines
  • NEWS
    Press Release Awards
  • CAREERS
  • CONTACT US
中文简体
中文简体 English
Search
/uploads/image/img/banner-txt-en-03.svg
首页 -NEWS -Press Release
  • Press Release
  • Awards
Press Release
Awards
  • Beihai Biotech announced that its innovative cancer drug, BH009 (marketed as BEIZRAY), has received approval from the U.S. Food and Drug Administration (FDA)
    Beihai Biotech announced that its innovative cancer drug, BH009 (marketed as BEIZRAY), has received approval from the U.S. Food and Drug Administration (FDA)
    2024-10-31
  • U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009  (BEIZRAY™)
    U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY™)
    2024-01-04
  • Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School
    Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School
    2023-12-26
  • Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates
    Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates
    2023-12-19
  • Beihai Biotech Secures “Drug Manufacturing Certificate”
    Beihai Biotech Secures “Drug Manufacturing Certificate”
    2023-06-15
  • Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023
    Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023
    2023-06-12
  • 安博在线客服用于治疗晚期三阴性乳腺癌的创新药物BH009获批开展II期临床试验
    安博在线客服用于治疗晚期三阴性乳腺癌的创新药物BH009获批开展II期临床试验
    2023-04-10
  • 安博在线客服BH009新药项目在晚期头颈部鳞癌和卵巢癌患者中的I期临床试验完成首例患者给药
    安博在线客服BH009新药项目在晚期头颈部鳞癌和卵巢癌患者中的I期临床试验完成首例患者给药
    2023-03-09
<< 1234 >>
  • ABOUT US
  • R&D
  • NEWS
  • CAREERS
  • CONTACT US
Contact Information
Company address:Blg 2, No. 6366, Zhuhai Ave., Jinwan, Zhuhai, 519090, China
Tel:0756-6349669
Human resources contact:hr@bayhibiotech.com
Business cooperation contact:hjiang@bayhibiotech.com
Wechat Official Account
Wechat Official Account
Copyright © 2023 Zhuhai Beihai Biotech Co., Ltd.Copyright Registration No. :Guangdong ICP for 17134092Technical support : Xiangxun Technology
中欧官方网站 | 星空网页版登录入口_星空(中国) | XINGKONG.COM | 拼搏平台 | 开云手机站·官方版在线 | 拼搏 | 中欧手机版app | 安博在线客服 | 开云在线登陆入口_开云(中国) |